Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 17456544)

Published in Ann Pharmacother on April 24, 2007

Authors

Michael P Dorsch1, Jin Sun Lee, Donald R Lynch, Steven P Dunn, Jo E Rodgers, Todd Schwartz, Emily Colby, Debbie Montague, Susan S Smyth

Author Affiliations

1: Department of Pharmacy Services, University of Michigan Hospitals and Health Centers, Ann Arbor, MI, USA.

Articles by these authors

Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Arch Intern Med (2008) 3.68

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol (2002) 2.50

Rap1b is required for normal platelet function and hemostasis in mice. J Clin Invest (2005) 2.46

Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation. Blood (2011) 2.27

The effect of donor age on corneal transplantation outcome results of the cornea donor study. Ophthalmology (2008) 2.19

Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results. Ophthalmology (2008) 1.94

Structural basis of substrate discrimination and integrin binding by autotaxin. Nat Struct Mol Biol (2011) 1.81

Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation. Proc Natl Acad Sci U S A (2010) 1.80

Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis. J Biol Chem (2009) 1.78

Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal- and background-dependent development of concentric left ventricular hypertrophy. Am J Physiol Heart Circ Physiol (2006) 1.52

Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation. Crit Care Med (2008) 1.41

Recipient risk factors for graft failure in the cornea donor study. Ophthalmology (2009) 1.40

Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway. Atherosclerosis (2009) 1.33

Correlates of mother-premature infant interactions. Res Nurs Health (2007) 1.31

Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. J Card Fail (2010) 1.30

Therapeutic potential of autotaxin/lysophospholipase d inhibitors. Curr Drug Targets (2008) 1.27

Importance of direct patient care in advanced pharmacy practice experiences. Pharmacotherapy (2012) 1.26

Dominant-negative loss of PPARgamma function enhances smooth muscle cell proliferation, migration, and vascular remodeling. Arterioscler Thromb Vasc Biol (2009) 1.23

The effect of donor age on penetrating keratoplasty for endothelial disease: graft survival after 10 years in the Cornea Donor Study. Ophthalmology (2013) 1.23

Autotaxin and its product lysophosphatidic acid suppress brown adipose differentiation and promote diet-induced obesity in mice. Mol Endocrinol (2012) 1.21

Self-management education for persons with arthritis: Managing comorbidity and eliminating health disparities. Arthritis Rheum (2007) 1.20

Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure. Circ Res (2008) 1.20

Characterization of a model to independently study regression of ventricular hypertrophy. J Surg Res (2007) 1.19

Src family kinases mediate neutrophil adhesion to adherent platelets. Blood (2006) 1.16

Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation. Am J Respir Crit Care Med (2013) 1.15

The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema. Ann Pharmacother (2011) 1.12

Binding of autotaxin to integrins localizes lysophosphatidic acid production to platelets and mammalian cells. J Biol Chem (2011) 1.11

Integrin αIIbβ3: from discovery to efficacious therapeutic target. Circ Res (2013) 1.11

Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions. Clin Sci (Lond) (2011) 1.10

Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice. J Lipid Res (2013) 1.09

Prasugrel versus clopidogrel for acute coronary syndromes. N Engl J Med (2013) 1.08

Mice with targeted inactivation of ppap2b in endothelial and hematopoietic cells display enhanced vascular inflammation and permeability. Arterioscler Thromb Vasc Biol (2014) 1.08

A phosphatidic acid binding/nuclear localization motif determines lipin1 function in lipid metabolism and adipogenesis. Mol Biol Cell (2010) 1.07

Sleeping and waking state development in preterm infants. Early Hum Dev (2004) 1.05

Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway. Nat Commun (2013) 1.05

Src-family kinases mediate an outside-in signal necessary for beta2 integrins to achieve full activation and sustain firm adhesion of polymorphonuclear leucocytes tethered on E-selectin. Biochem J (2006) 1.05

Lipid phosphate phosphatase 3 negatively regulates smooth muscle cell phenotypic modulation to limit intimal hyperplasia. Arterioscler Thromb Vasc Biol (2012) 1.04

Platelets as immune mediators: their role in host defense responses and sepsis. Thromb Res (2010) 1.04

CX3CR1 deficiency confers protection from intimal hyperplasia after arterial injury. Arterioscler Thromb Vasc Biol (2006) 1.04

Trends of presentation and clinical outcome of treated renal angiomyolipoma. Yonsei Med J (2010) 1.04

Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid. J Lipid Res (2013) 1.03

Thrombosis and antithrombotic therapy in women. Arterioscler Thromb Vasc Biol (2009) 1.03

Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway. Arterioscler Thromb Vasc Biol (2008) 1.02

Distinct roles for Rap1b protein in platelet secretion and integrin αIIbβ3 outside-in signaling. J Biol Chem (2011) 1.01

A randomized controlled trial of the people with arthritis can exercise program: symptoms, function, physical activity, and psychosocial outcomes. Arthritis Rheum (2008) 1.01

Pathological effects of prostate cancer correlate with neuroendocrine differentiation and PTEN expression after bicalutamide monotherapy. J Urol (2009) 1.00

Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ mice. Am J Physiol Heart Circ Physiol (2009) 0.99

Retrospective review of graft dislocation rate associated with descemet stripping automated endothelial keratoplasty after primary failed penetrating keratoplasty. Cornea (2011) 0.95

Evidence of mobilization of pluripotent stem cells into peripheral blood of patients with myocardial ischemia. Exp Hematol (2010) 0.92

Public health nursing case management for women receiving temporary assistance for needy families: a randomized controlled trial using community-based participatory research. Am J Public Health (2011) 0.92

Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways. Biochem J (2011) 0.91

Enhanced proliferation and migration of vascular smooth muscle cells in response to vascular injury under hyperglycemic conditions is controlled by beta3 integrin signaling. Int J Biochem Cell Biol (2010) 0.91

Imaging findings of invasive micropapillary carcinoma of the breast. J Breast Cancer (2012) 0.90

Functional characterization of the atypical integral membrane lipid phosphatase PDP1/PPAPDC2 identifies a pathway for interconversion of isoprenols and isoprenoid phosphates in mammalian cells. J Biol Chem (2010) 0.90

Measurement of autotaxin/lysophospholipase D activity. Methods Enzymol (2007) 0.90

Platelet secretion and hemostasis require syntaxin-binding protein STXBP5. J Clin Invest (2014) 0.89

Assessing Medicare Part D claim completeness using medication self-reports: the role of veteran status and Generic Drug Discount Programs. Med Care (2015) 0.89

Predictors of wheezing in prematurely born children. J Obstet Gynecol Neonatal Nurs (2008) 0.88

Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling. Arterioscler Thromb Vasc Biol (2011) 0.87

Comparison of deep lamellar endothelial keratoplasty and penetrating keratoplasty in patients with Fuchs endothelial dystrophy. Cornea (2008) 0.87

Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction. Stem Cells Dev (2013) 0.87

Considerable variability in platelet activity among patients with coronary artery disease in response to an increased maintenance dose of clopidogrel. Coron Artery Dis (2009) 0.86

Development of behaviors in preterm infants: relation to sleeping and waking. Nurs Res (2003) 0.86

CD40 is essential in the upregulation of TRAF proteins and NF-kappaB-dependent proinflammatory gene expression after arterial injury. PLoS One (2011) 0.85

Clinical characteristics of renal cell carcinoma in Korean patients with von Hippel-Lindau disease compared to sporadic bilateral or multifocal renal cell carcinoma. J Korean Med Sci (2009) 0.85

Type 2 diabetes mellitus and heart failure. Pharmacotherapy (2008) 0.85

Parent-of-origin effects on cardiac response to pressure overload in mice. Am J Physiol Heart Circ Physiol (2009) 0.84

Blood relatives: dynamic regulation of bioactive lysophosphatidic acid and sphingosine-1-phosphate metabolism in the circulation. Trends Cardiovasc Med (2009) 0.84

Magnolol-induced apoptosis in HCT-116 colon cancer cells is associated with the AMP-activated protein kinase signaling pathway. Biol Pharm Bull (2012) 0.84

Effects of unfractionated heparin and glycoprotein IIb/IIIa antagonists versus bivalirdin on myeloperoxidase release from neutrophils. Arterioscler Thromb Vasc Biol (2007) 0.84

Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness. J Thromb Thrombolysis (2013) 0.84

Supporting the mental health of mothers raising children in poverty: how do we target them for intervention studies? Ann N Y Acad Sci (2007) 0.84

Association of asymptomatic peripheral arterial disease with vascular events in patients with stroke or transient ischemic attack. Stroke (2009) 0.84

Respiratory development in preterm infants. J Perinatol (2004) 0.83

Emotional distress in African American women with HIV. J Prev Interv Community (2007) 0.83

Synergistic effect of anemia and red blood cells transfusion on inflammation and lung injury. Adv Hematol (2012) 0.83

Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. Am Heart J (2009) 0.83

Coronary artery remodeling in a model of left ventricular pressure overload is influenced by platelets and inflammatory cells. PLoS One (2012) 0.83

Integrin-mediated cell surface recruitment of autotaxin promotes persistent directional cell migration. FASEB J (2013) 0.83

Lysophosphatidic acid and cardiovascular disease: seeing is believing. J Lipid Res (2013) 0.82

Discharge counseling for patients with heart failure or myocardial infarction: a best practices model developed by members of the American College of Clinical Pharmacy's Cardiology Practice and Research Network based on the Hospital to Home (H2H) Initiative. Pharmacotherapy (2013) 0.82

Anticancer properties of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells. Biol Pharm Bull (2012) 0.82

Effects of hyperfibrinogenemia on vasculature of C57BL/6 mice with and without atherogenic diet. Arterioscler Thromb Vasc Biol (2003) 0.82

Clinical update on the management of atrial fibrillation. Pharmacotherapy (2013) 0.81

Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease. J Am Coll Cardiol (2012) 0.81

Lysophospholipids in coronary artery and chronic ischemic heart disease. Curr Opin Lipidol (2015) 0.81

Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy. Thromb Haemost (2014) 0.80

Acute decompensated heart failure: evolving literature and implications for future practice. Pharmacotherapy (2013) 0.80

Inflammation and thrombosis in cardiovascular disease. Curr Opin Hematol (2013) 0.79

Thymosin β4: a potential novel dry eye therapy. Ann N Y Acad Sci (2012) 0.79

Consensus review of the treatment of cardiovascular disease in people with hemophilia A and B. Cardiol Rev (2015) 0.79

Spontaneous coronary thrombosis following thrombolytic therapy for acute cardiovascular accident and stroke: a case study. J Thromb Thrombolysis (2012) 0.79

Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudy. J Thromb Thrombolysis (2011) 0.79

Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee. J Thromb Thrombolysis (2005) 0.78

Enhanced platelet reactivity and thrombosis in Apoe-/- mice exposed to cigarette smoke is attenuated by P2Y12 antagonism. Thromb Res (2010) 0.78

Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development. Arterioscler Thromb Vasc Biol (2010) 0.78